Reportedly, Walgreen Boots Alliance (WBA) to give a one-time bonus of $1,250 to its full-time pharmacists and a $1,000 payment to part-time pharmacists, as major retailers try to retain people amid an acute labor shortage, resulting in companies raising wages and providing incentives to employees ahead of the upcoming holiday season.
Also, the company informed that certified or to-be certified pharmacy technicians who are responsible for administering flu and COVID-19 vaccines will be given a $1,000 reward throughout a six-month retention period. Walgreens added that it will provide an incentive of $200 myWalgreens cash to any employee who gets fully vaccinated against COVID-19 by Nov. 30.
The retailer informed that a majority of the staff are vaccinated against COVID-19 and it was mandatory for support staff to be vaccinated or be enrolled in a regular testing program in line with government regulation.
Walgreen Boots Alliance (WBA) is a pharmacy-led, health and well-being enterprise with a long history of trusted healthcare services, community pharmacy care, and pharmaceutical wholesaling dates. To learn more about Walgreen Boots Alliance (WBA) and to continue to track its progress please visit the Vista Partners Walgreens Boots Alliance Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.